<DOC>
	<DOCNO>NCT01195324</DOCNO>
	<brief_summary>The purpose study assess effect multiple oral dos canagliflozin single oral dose warfarin .</brief_summary>
	<brief_title>A Drug Interaction Study Warfarin Canagliflozin Healthy Adult Volunteers</brief_title>
	<detailed_description>This open-label ( volunteer know name treatment assign ) single-center study canagliflozin ( JNJ-28431754 ) warfarin healthy adult volunteer . Canagliflozin drug currently development low blood sugar level patient type 2 diabetes mellitus warfarin approve anticoagulant ( ie , drug stop blood clot ) . After overnight fast ( without eat food ) least 10 hour , volunteer receive Sequence 1 ( canagliflozin 300 mg , orally , daily Days 1-12 single , oral 30 mg dose warfarin Day 6 [ Treatment A ] follow 14 day later single , oral 30 mg dose warfarin Day 1 [ Treatment B ] ) OR Sequence 2 ( Treatment B follow 14 day later Treatment A ) .</detailed_description>
	<mesh_term>Canagliflozin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Healthy volunteer body mass index 18 30 kg/m Any blood coagulation disorder determine clinically relevant Investigator Medications know affect coagulation take within 7 14 day study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Prothrombin time ( PT )</keyword>
	<keyword>International normalized ratio ( INR )</keyword>
</DOC>